Rheumatoid arthritis: Is it a coronary heart disease equivalent?

Holly John, Tracey E. Toms, George D. Kitas

    Research output: Contribution to journalArticlepeer-review


    PURPOSE OF REVIEW: This review examines current evidence to address the question whether rheumatoid arthritis (RA) is a coronary heart disease equivalent, similar to type 2 diabetes mellitus (DM2). RECENT FINDINGS: Cross-sectional and longitudinal epidemiological studies show a two-fold higher risk of cardiovascular disease (CVD) in patients with RA, and the magnitude of this increased risk is comparable to the risk associated with DM2. However, the mechanisms responsible for this appear to be different in the two conditions, with RA-related CVD being attributed to 'high-grade' systemic inflammation as well as classical CVD risk factors. Several classical risk factors are affected by RA or its medications, and there are some paradoxical associations between obesity or lipid abnormalities and CVD death in RA. SUMMARY: Management of RA-related CVD is likely to require both aggressive control of inflammation and systematic screening and management of classical CVD risk factors. It remains unknown whether primary prevention strategies applied successfully in DM2 would be equally easy to implement and demonstrate similar benefits in people with RA. © 2011 Lippincott Williams & Wilkins, Inc.
    Original languageEnglish
    Pages (from-to)327-333
    Number of pages6
    JournalCurrent Opinion in Cardiology
    Issue number4
    Publication statusPublished - Jul 2011


    • cardiovascular disease
    • cardiovascular risk
    • coronary heart disease equivalent
    • rheumatoid arthritis
    • type 2 diabetes mellitus


    Dive into the research topics of 'Rheumatoid arthritis: Is it a coronary heart disease equivalent?'. Together they form a unique fingerprint.

    Cite this